Skip to main content

Table 1 Clinical and demographic data

From: Exercise-induced intra-ventricular gradients as a frequent potential cause of myocardial ischemia in cardiac syndrome X patients

 

Group A

Group B

p

Age, years

47,70 ± 13,36

53,53 ± 10,89

0,026

Sex, female (%)

10/33 (30%)

34/58 (59%)

0,008

BSA m2

1,8 ± 0,16

1,73 ± 0,13

0,022

Effort Angina

28/33 (85%)

33/58 (56%)

0,006

Effortless Angina

9/33 (27%)

35/58 (57%)

0,002

Duration of symptoms before cath. (months)

15 ± 10

46 ± 40

0,000

Time of FLW (months)

36,4 ± 17,9

39,1 ± 19,5

0,55

Events in FLW

6/33 (18%)

8/56 (14%)

0,31

ACS in FLW

1/33 (3%)

7/56 (13%)

0,24

β Bloq.

7/33 (21%)

11/58 (19%)

0,798

CCB

4/33 (12%)

7/58 (12%)

0,666

Nitrates

16/33 (48%)

31/58 (53%)

0,769

IECA/ARAII

5/33 (15%)

7/58 (12%)

0,680

Diuretics

2/33 (6%)

5/58 (9%)

0,663

β Bloq. FLW

20/33 (60%)

17/56 (30%)

0,003

CCB FLW

4/33(12%)

19/56 (34%)

0,530

Nitrates FLW

9/33 (27%)

33/56 (59%)

0,006

IECA/ARAII FLW

9/33 (27%)

8/56 (14%)

0,068

Diuretics FLW

4/33(12%)

4/56 (7%)

0,403

  1. BSA – body surface area; ACS – Acute coronary Syndrome; CCB – Calcium chanell blockers; FLW – follow-up